iShares Global Healthcare ETF

Health/Biotechnology

IXJ

400 Howard Street,
San Francisco , CA, 94105

Price

  • $ 91.34 0 % +0.15
    Dec 9, 2024
  • Last Close
  • Net Assets
  • $4B
    Feb 26, 2024
  • 52-Week High/Low
  • $94.27 - $84.28

  • Expense Ratio
  • -

Link

Directors

Jun 14, 2023
  • John E. Kerrigan
  • Richard L. Fagnani
  • Robert S. Kapito
  • Drew E. Lawton
  • John E. Martinez
  • Salim Ramji
  • Madhav V. Rajan
  • Jane D. Carlin
  • Cecilia H. Herbert

Chief Compliance Officer

  • Charles Park

Company Name

Holding

More 1.13 %

Documents

Prospectus

link

Annual Reports

link

Returns +
Q

2026 2025 2024 2023 2022 2021
Q1 - - 7.4% -1.8% -2.4% 0.8%
Q2 - - -2% 2% -7.4% 9.2%
Q3 - - - -3% -7.1% 0.7%
Q4 - - - 5.6% 12.7% 7.9%

Returns +
M

J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 - - - - - - - - - - - -

Returns +
A

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
    0%0%4.5%2.2%-5.4%18.8%9.9%21.4%2.8%20.4%-6%

Alpha IXJ and S&P 500

IXJ and S&P 500

Chart +